================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) January 27, 2006
VARIAN MEDICAL SYSTEMS, INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 1-7598 94-2359345
---------------------------- ---------------- -------------------
(State or Other Jurisdiction (Commission File (IRS Employer
of Incorporation) Number) Identification No.)
3100 Hansen Way, Palo Alto, CA 94304-1030
---------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (650) 493-4000
Not Applicable
-------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
Item 2.02. Results of Operation and Financial Condition.
On January 27, 2006, Varian Medical Systems, Inc. (the "Company")
posted, on the investor relations webpage of its website www.varian.com,
"Consolidated Statement of Earnings (Adjusted for the Change in Segment
Reporting) Fiscal Year 2005 and Fiscal Year 2004 (Unaudited)" showing for fiscal
years 2005 and 2004 the Company's reporting segments, with the Oncology Systems
segment adjusted to include the BrachyTherapy unit and exclude the Security and
Inspection Products business, and the "Other" category adjusted to include the
Security and Inspection Products business and Ginzton Technology Center and
exclude the BrachyTherapy unit. A copy of the Consolidated Statement of Earnings
is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Please note that information on, or that can be accessed through, the
Company's website is not to be incorporated by reference into this Current
Report on Form 8-K or into any of the Company's other filings under the
Securities Act of 1933, as amended, or Securities Exchange Act of 1934, as
amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Consolidated Statement of Earnings (Adjusted for the Change in
Segment Reporting) Fiscal Year 2005 and Fiscal Year 2004 (Unaudited).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Varian Medical Systems, Inc.
By: /s/ JOHN W. KUO
-----------------------------
Name: John W. Kuo
Title: Corporate Vice President,
General Counsel and Secretary
Dated: January 31, 2006
EXHIBIT INDEX
Number Exhibit
------ -----------------------------------------------------------------------
99.1 Consolidated Statement of Earnings (Adjusted for the Change in Segment
Reporting) Fiscal Year 2005 and Fiscal Year 2004 (Unaudited).